Share Price and Basic Stock Data
Last Updated: December 30, 2025, 7:10 am
| PEG Ratio | 29.42 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
S H Kelkar & Company Ltd (SHK) operates in the chemicals sector, specializing in diverse chemical products. As of the latest reporting period, the company’s stock price stood at ₹179 with a market capitalization of ₹2,480 Cr. SHK reported a total revenue of ₹2,245 Cr for the trailing twelve months (TTM), reflecting a steady growth trajectory from ₹1,687 Cr in FY 2023 and ₹1,564 Cr in FY 2022. Quarterly sales figures indicate resilience, with ₹455.44 Cr in September 2023 and a projected rise to ₹513.34 Cr by March 2024. The company’s operating profit margin (OPM) remained consistent, averaging 14.85% in FY 2024, up from 13% in FY 2023, showcasing effective cost management amidst fluctuating raw material prices. Overall, SHK’s revenue growth reflects a robust demand for its product offerings, aligning with broader sector trends that indicate increasing consumption in the chemicals market. This sustained growth is critical for maintaining investor confidence and supporting future expansion initiatives.
Profitability and Efficiency Metrics
SHK’s profitability metrics illustrate a mixed performance, with a reported net profit of ₹155 Cr for the TTM, down from ₹149 Cr in FY 2022. The company’s return on equity (ROE) stood at 7.70%, while return on capital employed (ROCE) was recorded at 10.3%, indicating a moderately efficient utilization of capital. The operating profit for the recent quarter was ₹71.63 Cr, resulting in an OPM of 15.73%, which aligns with industry averages but reflects a decline from previous periods. Moreover, the interest coverage ratio (ICR) was strong at 6.49x, indicating that SHK comfortably meets its interest obligations. However, the company experienced fluctuations in net profit, particularly a notable decline to -₹86.82 Cr in June 2024, highlighting potential volatility in operational performance. This inconsistency in profitability metrics suggests that while SHK maintains a solid operational base, external factors may impact its bottom line significantly.
Balance Sheet Strength and Financial Ratios
SHK’s balance sheet presents a mixed picture of financial health. The total assets increased to ₹2,805 Cr as of September 2025, supported by reserves that grew to ₹1,191 Cr. The company’s borrowings stood at ₹889 Cr, reflecting a manageable debt level with a debt-to-equity ratio of 0.58x, which indicates a conservative approach to leveraging. The current ratio was reported at 1.39, suggesting adequate liquidity to meet short-term obligations. However, the cash conversion cycle (CCC) of 187 days may indicate potential inefficiencies in managing receivables and inventory. Additionally, the price-to-book value (P/BV) ratio of 1.93x aligns with industry norms, suggesting that the stock is reasonably valued relative to its book assets. Overall, while the balance sheet shows a solid capital structure, the higher CCC may raise concerns about cash flow management and operational efficiency.
Shareholding Pattern and Investor Confidence
SHK’s shareholding pattern reflects a stable structure with promoters holding 54.87% of the company as of September 2025, down from 58.47% in December 2022. Institutional investors, including foreign institutional investors (FIIs) and domestic institutional investors (DIIs), held 7.36% and 5.69%, respectively, indicating a moderate level of institutional interest. The public shareholding accounted for 32.08%, showing a healthy distribution among retail investors. The gradual decrease in promoter holding may raise questions about insider confidence; however, the stable institutional presence suggests ongoing support for the company. The number of shareholders increased to 50,971, indicating growing interest in SHK’s equity. This diversification in the shareholder base can enhance liquidity and potentially stabilize stock performance in turbulent market conditions, fostering a more resilient investor sentiment.
Outlook, Risks, and Final Insight
Looking ahead, SHK faces both opportunities and challenges. The chemicals sector is poised for growth, driven by increasing demand across various industries, which could enhance SHK’s revenue potential. However, the company must navigate risks such as fluctuating raw material costs, which can impact profitability margins. The volatility in net profit, particularly the significant loss in June 2024, underscores the need for improved operational efficiency and cost control measures. Additionally, the higher cash conversion cycle poses a risk to liquidity and operational fluidity. If SHK can effectively manage these challenges while capitalizing on market opportunities, it stands to enhance its competitive position. Conversely, failure to address these risks may hinder growth prospects and affect investor confidence. Overall, SHK’s strategic focus on innovation and operational excellence will be crucial in determining its future trajectory in the competitive chemicals landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 259 Cr. | 265 | 514/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 27.8 Cr. | 66.2 | 90.0/56.0 | 15.2 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,021 Cr. | 75.3 | 100/64.9 | 12.8 | 121 | 1.06 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 950 Cr. | 106 | 130/63.6 | 9.49 | 109 | 1.14 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 91,177 Cr. | 3,076 | 3,325/2,200 | 56.4 | 447 | 0.23 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,618.89 Cr | 1,168.89 | 33.17 | 204.33 | 0.41% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 414.18 | 384.90 | 472.43 | 422.56 | 455.44 | 471.68 | 513.34 | 470.31 | 542.50 | 543.21 | 567.38 | 580.63 | 553.89 |
| Expenses | 362.52 | 341.46 | 405.18 | 354.61 | 383.81 | 395.82 | 423.80 | 392.05 | 462.38 | 479.56 | 493.95 | 507.62 | 501.50 |
| Operating Profit | 51.66 | 43.44 | 67.25 | 67.95 | 71.63 | 75.86 | 89.54 | 78.26 | 80.12 | 63.65 | 73.43 | 73.01 | 52.39 |
| OPM % | 12.47% | 11.29% | 14.23% | 16.08% | 15.73% | 16.08% | 17.44% | 16.64% | 14.77% | 11.72% | 12.94% | 12.57% | 9.46% |
| Other Income | 8.99 | 1.53 | -20.44 | 1.62 | 1.80 | 1.90 | -0.18 | -120.29 | 20.65 | 0.89 | 61.15 | 3.04 | 1.06 |
| Interest | 5.08 | 6.35 | 7.47 | 9.82 | 9.95 | 10.35 | 10.04 | 9.89 | 12.82 | 13.82 | 12.89 | 13.07 | 13.91 |
| Depreciation | 20.42 | 19.72 | 20.52 | 20.85 | 22.31 | 21.68 | 22.03 | 22.49 | 24.18 | 23.35 | 24.68 | 26.37 | 27.38 |
| Profit before tax | 35.15 | 18.90 | 18.82 | 38.90 | 41.17 | 45.73 | 57.29 | -74.41 | 63.77 | 27.37 | 97.01 | 36.61 | 12.16 |
| Tax % | 28.22% | 29.31% | 94.00% | 28.46% | 26.74% | 29.74% | 41.65% | 16.68% | 37.57% | 36.02% | -5.67% | 30.21% | 24.59% |
| Net Profit | 25.23 | 13.36 | 1.13 | 27.83 | 30.16 | 32.13 | 33.43 | -86.82 | 39.81 | 17.51 | 102.51 | 25.55 | 9.17 |
| EPS in Rs | 1.75 | 0.94 | 0.17 | 1.96 | 2.12 | 2.33 | 2.45 | -6.25 | 2.87 | 1.27 | 7.41 | 1.85 | 0.66 |
Last Updated: December 29, 2025, 7:36 am
Below is a detailed analysis of the quarterly data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 553.89 Cr.. The value appears to be declining and may need further review. It has decreased from 580.63 Cr. (Jun 2025) to 553.89 Cr., marking a decrease of 26.74 Cr..
- For Expenses, as of Sep 2025, the value is 501.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 507.62 Cr. (Jun 2025) to 501.50 Cr., marking a decrease of 6.12 Cr..
- For Operating Profit, as of Sep 2025, the value is 52.39 Cr.. The value appears to be declining and may need further review. It has decreased from 73.01 Cr. (Jun 2025) to 52.39 Cr., marking a decrease of 20.62 Cr..
- For OPM %, as of Sep 2025, the value is 9.46%. The value appears to be declining and may need further review. It has decreased from 12.57% (Jun 2025) to 9.46%, marking a decrease of 3.11%.
- For Other Income, as of Sep 2025, the value is 1.06 Cr.. The value appears to be declining and may need further review. It has decreased from 3.04 Cr. (Jun 2025) to 1.06 Cr., marking a decrease of 1.98 Cr..
- For Interest, as of Sep 2025, the value is 13.91 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.07 Cr. (Jun 2025) to 13.91 Cr., marking an increase of 0.84 Cr..
- For Depreciation, as of Sep 2025, the value is 27.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 26.37 Cr. (Jun 2025) to 27.38 Cr., marking an increase of 1.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.16 Cr.. The value appears to be declining and may need further review. It has decreased from 36.61 Cr. (Jun 2025) to 12.16 Cr., marking a decrease of 24.45 Cr..
- For Tax %, as of Sep 2025, the value is 24.59%. The value appears to be improving (decreasing) as expected. It has decreased from 30.21% (Jun 2025) to 24.59%, marking a decrease of 5.62%.
- For Net Profit, as of Sep 2025, the value is 9.17 Cr.. The value appears to be declining and may need further review. It has decreased from 25.55 Cr. (Jun 2025) to 9.17 Cr., marking a decrease of 16.38 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.66. The value appears to be declining and may need further review. It has decreased from 1.85 (Jun 2025) to 0.66, marking a decrease of 1.19.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 761 | 834 | 925 | 981 | 1,021 | 1,048 | 1,114 | 1,322 | 1,564 | 1,687 | 1,841 | 2,123 | 2,245 |
| Expenses | 628 | 716 | 774 | 814 | 862 | 908 | 955 | 1,083 | 1,350 | 1,469 | 1,537 | 1,828 | 1,983 |
| Operating Profit | 132 | 119 | 151 | 167 | 159 | 141 | 160 | 239 | 215 | 217 | 304 | 296 | 262 |
| OPM % | 17% | 14% | 16% | 17% | 16% | 13% | 14% | 18% | 14% | 13% | 17% | 14% | 12% |
| Other Income | 12 | 25 | 10 | 12 | 13 | 21 | -28 | 36 | 6 | -8 | 5 | -38 | 66 |
| Interest | 18 | 19 | 22 | 6 | 5 | 16 | 26 | 20 | 16 | 24 | 40 | 49 | 54 |
| Depreciation | 19 | 29 | 30 | 19 | 24 | 31 | 52 | 62 | 72 | 80 | 86 | 95 | 102 |
| Profit before tax | 109 | 94 | 110 | 153 | 143 | 115 | 54 | 194 | 132 | 104 | 183 | 114 | 173 |
| Tax % | 27% | 26% | 34% | 31% | 35% | 24% | 34% | 26% | -13% | 40% | 32% | 36% | |
| Net Profit | 79 | 70 | 73 | 105 | 94 | 88 | 36 | 144 | 149 | 63 | 124 | 73 | 155 |
| EPS in Rs | 5,980.35 | 5.32 | 5.05 | 7.25 | 6.49 | 6.12 | 2.53 | 10.24 | 10.73 | 4.42 | 8.84 | 5.29 | 11.19 |
| Dividend Payout % | 19% | 28% | 30% | 24% | 27% | 0% | 38% | 17% | 7% | 45% | 8% | 19% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -11.39% | 4.29% | 43.84% | -10.48% | -6.38% | -59.09% | 300.00% | 3.47% | -57.72% | 96.83% | -41.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 15.68% | 39.55% | -54.31% | 4.09% | -52.71% | 359.09% | -296.53% | -61.19% | 154.54% | -137.95% |
S H Kelkar & Company Ltd (SHK) has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 14% |
| 3 Years: | 11% |
| TTM: | 17% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 11% |
| 3 Years: | -15% |
| TTM: | 15% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 27% |
| 3 Years: | 21% |
| 1 Year: | 9% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:15 pm
Balance Sheet
Last Updated: December 4, 2025, 1:54 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 132 | 145 | 145 | 145 | 145 | 141 | 141 | 138 | 138 | 138 | 138 | 138 |
| Reserves | 467 | 368 | 571 | 667 | 712 | 719 | 683 | 810 | 875 | 926 | 1,074 | 1,134 | 1,191 |
| Borrowings | 212 | 252 | 85 | 74 | 172 | 342 | 365 | 518 | 698 | 620 | 666 | 832 | 889 |
| Other Liabilities | 169 | 187 | 201 | 187 | 246 | 222 | 277 | 405 | 568 | 518 | 502 | 556 | 587 |
| Total Liabilities | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
| Fixed Assets | 251 | 274 | 227 | 296 | 352 | 462 | 472 | 741 | 959 | 914 | 933 | 953 | 1,052 |
| CWIP | 50 | 10 | 18 | 7 | 60 | 38 | 18 | 28 | 9 | 26 | 13 | 46 | 59 |
| Investments | 0 | 0 | 35 | 50 | 96 | 97 | 97 | 1 | 1 | 23 | 10 | 11 | 13 |
| Other Assets | 559 | 655 | 722 | 720 | 767 | 830 | 879 | 1,103 | 1,309 | 1,239 | 1,425 | 1,650 | 1,681 |
| Total Assets | 861 | 939 | 1,003 | 1,073 | 1,275 | 1,427 | 1,466 | 1,874 | 2,279 | 2,202 | 2,381 | 2,660 | 2,805 |
Below is a detailed analysis of the balance sheet data for S H Kelkar & Company Ltd (SHK) based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 138.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 138.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,191.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,134.00 Cr. (Mar 2025) to 1,191.00 Cr., marking an increase of 57.00 Cr..
- For Borrowings, as of Sep 2025, the value is 889.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 832.00 Cr. (Mar 2025) to 889.00 Cr., marking an increase of 57.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 587.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2025) to 587.00 Cr., marking an increase of 31.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,805.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,052.00 Cr.. The value appears strong and on an upward trend. It has increased from 953.00 Cr. (Mar 2025) to 1,052.00 Cr., marking an increase of 99.00 Cr..
- For CWIP, as of Sep 2025, the value is 59.00 Cr.. The value appears strong and on an upward trend. It has increased from 46.00 Cr. (Mar 2025) to 59.00 Cr., marking an increase of 13.00 Cr..
- For Investments, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,681.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,650.00 Cr. (Mar 2025) to 1,681.00 Cr., marking an increase of 31.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,805.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,660.00 Cr. (Mar 2025) to 2,805.00 Cr., marking an increase of 145.00 Cr..
Notably, the Reserves (1,191.00 Cr.) exceed the Borrowings (889.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -80.00 | -133.00 | 66.00 | 93.00 | -13.00 | -201.00 | -205.00 | -279.00 | -483.00 | -403.00 | -362.00 | -536.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 85 | 90 | 81 | 99 | 99 | 104 | 103 | 108 | 95 | 97 | 87 |
| Inventory Days | 255 | 252 | 239 | 247 | 233 | 239 | 201 | 216 | 225 | 228 | 243 | 227 |
| Days Payable | 80 | 76 | 116 | 78 | 104 | 86 | 103 | 125 | 143 | 138 | 132 | 126 |
| Cash Conversion Cycle | 261 | 261 | 213 | 250 | 228 | 252 | 202 | 195 | 190 | 185 | 209 | 187 |
| Working Capital Days | 157 | 70 | 135 | 128 | 110 | 86 | 55 | 91 | 90 | 88 | 63 | 62 |
| ROCE % | 18% | 14% | 17% | 19% | 17% | 12% | 10% | 15% | 10% | 8% | 12% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Bandhan Small Cap Fund | 5,180,624 | 0.49 | 88.62 | 3,942,304 | 2025-12-15 00:19:01 | 31.41% |
| LIC MF Small Cap Fund | 319,836 | 0.88 | 5.47 | N/A | N/A | N/A |
| LIC MF Balanced Advantage Fund | 303,558 | 0.69 | 5.19 | N/A | N/A | N/A |
| LIC MF Focused Fund | 301,129 | 2.98 | 5.15 | N/A | N/A | N/A |
| LIC MF Dividend Yield Fund | 294,810 | 0.72 | 5.04 | N/A | N/A | N/A |
| Tata Childrens Fund | 150,000 | 0.7 | 2.57 | N/A | N/A | N/A |
| LIC MF Value Fund | 119,795 | 1 | 2.05 | 125,240 | 2025-12-15 00:19:01 | -4.35% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Diluted EPS (Rs.) | 5.31 | 8.93 | 4.53 | 10.81 | 10.48 |
| Cash EPS (Rs.) | 12.22 | 15.38 | 10.37 | 15.98 | 14.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 91.89 | 87.62 | 79.66 | 79.01 | 67.55 |
| Revenue From Operations / Share (Rs.) | 153.40 | 139.43 | 121.84 | 113.00 | 93.54 |
| PBDIT / Share (Rs.) | 23.18 | 22.60 | 16.55 | 16.77 | 18.35 |
| PBIT / Share (Rs.) | 16.34 | 16.15 | 10.74 | 11.59 | 14.00 |
| PBT / Share (Rs.) | 8.39 | 13.17 | 7.55 | 9.55 | 13.68 |
| Net Profit / Share (Rs.) | 5.37 | 8.93 | 4.56 | 10.79 | 10.17 |
| NP After MI And SOA / Share (Rs.) | 5.29 | 8.84 | 4.42 | 10.73 | 10.24 |
| PBDIT Margin (%) | 15.11 | 16.21 | 13.58 | 14.84 | 19.61 |
| PBIT Margin (%) | 10.65 | 11.58 | 8.81 | 10.25 | 14.96 |
| PBT Margin (%) | 5.47 | 9.44 | 6.19 | 8.45 | 14.62 |
| Net Profit Margin (%) | 3.50 | 6.40 | 3.74 | 9.55 | 10.87 |
| NP After MI And SOA Margin (%) | 3.44 | 6.34 | 3.62 | 9.49 | 10.94 |
| Return on Networth / Equity (%) | 5.75 | 10.09 | 5.74 | 14.66 | 15.20 |
| Return on Capital Employeed (%) | 14.55 | 15.22 | 9.82 | 10.20 | 14.93 |
| Return On Assets (%) | 2.72 | 5.09 | 2.75 | 6.46 | 7.62 |
| Long Term Debt / Equity (X) | 0.13 | 0.14 | 0.29 | 0.35 | 0.34 |
| Total Debt / Equity (X) | 0.58 | 0.50 | 0.53 | 0.62 | 0.51 |
| Asset Turnover Ratio (%) | 0.83 | 0.83 | 0.74 | 0.55 | 0.60 |
| Current Ratio (X) | 1.39 | 1.46 | 1.70 | 1.70 | 1.82 |
| Quick Ratio (X) | 0.75 | 0.75 | 0.85 | 0.93 | 1.07 |
| Inventory Turnover Ratio (X) | 3.09 | 3.06 | 1.72 | 1.58 | 1.82 |
| Dividend Payout Ratio (NP) (%) | 14.17 | 22.61 | 16.96 | 7.13 | 9.76 |
| Dividend Payout Ratio (CP) (%) | 6.18 | 13.07 | 7.32 | 4.81 | 6.85 |
| Earning Retention Ratio (%) | 85.83 | 77.39 | 83.04 | 92.87 | 90.24 |
| Cash Earning Retention Ratio (%) | 93.82 | 86.93 | 92.68 | 95.19 | 93.15 |
| Interest Coverage Ratio (X) | 6.49 | 7.58 | 9.59 | 14.35 | 15.19 |
| Interest Coverage Ratio (Post Tax) (X) | 3.75 | 3.99 | 4.49 | 10.97 | 8.69 |
| Enterprise Value (Cr.) | 3118.96 | 3356.30 | 1912.25 | 2576.78 | 1935.94 |
| EV / Net Operating Revenue (X) | 1.47 | 1.74 | 1.13 | 1.65 | 1.46 |
| EV / EBITDA (X) | 9.72 | 10.73 | 8.35 | 11.10 | 7.46 |
| MarketCap / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| Retention Ratios (%) | 85.82 | 77.38 | 83.03 | 92.86 | 90.23 |
| Price / BV (X) | 1.93 | 2.34 | 1.29 | 1.96 | 1.66 |
| Price / Net Operating Revenue (X) | 1.16 | 1.47 | 0.81 | 1.27 | 1.19 |
| EarningsYield | 0.02 | 0.04 | 0.04 | 0.07 | 0.09 |
After reviewing the key financial ratios for S H Kelkar & Company Ltd (SHK), here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Diluted EPS (Rs.), as of Mar 25, the value is 5.31. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.31, marking a decrease of 3.62.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 15.38 (Mar 24) to 12.22, marking a decrease of 3.16.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 91.89. It has increased from 87.62 (Mar 24) to 91.89, marking an increase of 4.27.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 153.40. It has increased from 139.43 (Mar 24) to 153.40, marking an increase of 13.97.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 23.18. This value is within the healthy range. It has increased from 22.60 (Mar 24) to 23.18, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 16.34, marking an increase of 0.19.
- For PBT / Share (Rs.), as of Mar 25, the value is 8.39. This value is within the healthy range. It has decreased from 13.17 (Mar 24) to 8.39, marking a decrease of 4.78.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 5.37. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.37, marking a decrease of 3.56.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 5.29. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 5.29, marking a decrease of 3.55.
- For PBDIT Margin (%), as of Mar 25, the value is 15.11. This value is within the healthy range. It has decreased from 16.21 (Mar 24) to 15.11, marking a decrease of 1.10.
- For PBIT Margin (%), as of Mar 25, the value is 10.65. This value is within the healthy range. It has decreased from 11.58 (Mar 24) to 10.65, marking a decrease of 0.93.
- For PBT Margin (%), as of Mar 25, the value is 5.47. This value is below the healthy minimum of 10. It has decreased from 9.44 (Mar 24) to 5.47, marking a decrease of 3.97.
- For Net Profit Margin (%), as of Mar 25, the value is 3.50. This value is below the healthy minimum of 5. It has decreased from 6.40 (Mar 24) to 3.50, marking a decrease of 2.90.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.44. This value is below the healthy minimum of 8. It has decreased from 6.34 (Mar 24) to 3.44, marking a decrease of 2.90.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.75. This value is below the healthy minimum of 15. It has decreased from 10.09 (Mar 24) to 5.75, marking a decrease of 4.34.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.55. This value is within the healthy range. It has decreased from 15.22 (Mar 24) to 14.55, marking a decrease of 0.67.
- For Return On Assets (%), as of Mar 25, the value is 2.72. This value is below the healthy minimum of 5. It has decreased from 5.09 (Mar 24) to 2.72, marking a decrease of 2.37.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.14 (Mar 24) to 0.13, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.58, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. There is no change compared to the previous period (Mar 24) which recorded 0.83.
- For Current Ratio (X), as of Mar 25, the value is 1.39. This value is below the healthy minimum of 1.5. It has decreased from 1.46 (Mar 24) to 1.39, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.75.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.09. This value is below the healthy minimum of 4. It has increased from 3.06 (Mar 24) to 3.09, marking an increase of 0.03.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.17. This value is below the healthy minimum of 20. It has decreased from 22.61 (Mar 24) to 14.17, marking a decrease of 8.44.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 6.18. This value is below the healthy minimum of 20. It has decreased from 13.07 (Mar 24) to 6.18, marking a decrease of 6.89.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.83. This value exceeds the healthy maximum of 70. It has increased from 77.39 (Mar 24) to 85.83, marking an increase of 8.44.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 93.82. This value exceeds the healthy maximum of 70. It has increased from 86.93 (Mar 24) to 93.82, marking an increase of 6.89.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.49. This value is within the healthy range. It has decreased from 7.58 (Mar 24) to 6.49, marking a decrease of 1.09.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.75. This value is within the healthy range. It has decreased from 3.99 (Mar 24) to 3.75, marking a decrease of 0.24.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,118.96. It has decreased from 3,356.30 (Mar 24) to 3,118.96, marking a decrease of 237.34.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.47. This value is within the healthy range. It has decreased from 1.74 (Mar 24) to 1.47, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.72. This value is within the healthy range. It has decreased from 10.73 (Mar 24) to 9.72, marking a decrease of 1.01.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For Retention Ratios (%), as of Mar 25, the value is 85.82. This value exceeds the healthy maximum of 70. It has increased from 77.38 (Mar 24) to 85.82, marking an increase of 8.44.
- For Price / BV (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has decreased from 2.34 (Mar 24) to 1.93, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.16. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.16, marking a decrease of 0.31.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in S H Kelkar & Company Ltd (SHK):
- Net Profit Margin: 3.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.55% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.75% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.8 (Industry average Stock P/E: 33.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.58
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | Devkaran Mansion, Mumbai Maharashtra 400002 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Vaze | Chairman & Non-Exe.Director |
| Mr. Kedar Vaze | WholeTime Director & Group CEO |
| Mrs. Prabha Vaze | Non Executive Director |
| Mr. Deepak Raj Bindra | Independent Director |
| Mr. Shrikant Oka | Independent Director |
| Mr. Vasant Gujarathi | Independent Director |
| Ms. Neela Bhattacherjee | Independent Director |
FAQ
What is the intrinsic value of S H Kelkar & Company Ltd (SHK)?
S H Kelkar & Company Ltd (SHK)'s intrinsic value (as of 30 December 2025) is 147.63 which is 17.53% lower the current market price of 179.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,474 Cr. market cap, FY2025-2026 high/low of 276/142, reserves of ₹1,191 Cr, and liabilities of 2,805 Cr.
What is the Market Cap of S H Kelkar & Company Ltd (SHK)?
The Market Cap of S H Kelkar & Company Ltd (SHK) is 2,474 Cr..
What is the current Stock Price of S H Kelkar & Company Ltd (SHK) as on 30 December 2025?
The current stock price of S H Kelkar & Company Ltd (SHK) as on 30 December 2025 is 179.
What is the High / Low of S H Kelkar & Company Ltd (SHK) stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of S H Kelkar & Company Ltd (SHK) stocks is 276/142.
What is the Stock P/E of S H Kelkar & Company Ltd (SHK)?
The Stock P/E of S H Kelkar & Company Ltd (SHK) is 24.8.
What is the Book Value of S H Kelkar & Company Ltd (SHK)?
The Book Value of S H Kelkar & Company Ltd (SHK) is 96.1.
What is the Dividend Yield of S H Kelkar & Company Ltd (SHK)?
The Dividend Yield of S H Kelkar & Company Ltd (SHK) is 0.56 %.
What is the ROCE of S H Kelkar & Company Ltd (SHK)?
The ROCE of S H Kelkar & Company Ltd (SHK) is 10.3 %.
What is the ROE of S H Kelkar & Company Ltd (SHK)?
The ROE of S H Kelkar & Company Ltd (SHK) is 7.70 %.
What is the Face Value of S H Kelkar & Company Ltd (SHK)?
The Face Value of S H Kelkar & Company Ltd (SHK) is 10.0.